Rss Feed
Molecular changes in the liver of space travelers provide clues about aging
What happens to the human body in space may help scientists create new anti-aging therapies.
New study identifies potential compound for pancreatic cancer treatment
Announcing a new article publication in BIO Integration. Fat mass and obesity-associated protein (FTO), an epitranscriptomic regulator, has been implicated in cancer progression and immune regulation but the therapeutic relevance in pancreatic cancer is unclear.
Researchers identify brain circuits responsible for triggering OCD symptoms
Most of the time, the origin of obsessive-compulsive disorder (OCD) is unknown, but in some rare cases, it starts after a brain injury, such as a stroke or a tumor.
USC researcher wins NIH grant to study how the cochlea processes complex sounds
USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project (R01) grant to study how the cochlea, the part of the inner ear responsible for hearing, processes complex sounds encountered in everyday life.
Telepractice resilience program helps stuttering children build coping skills
A new University of Mississippi-led study suggests that a telepractice resilience program may help children who stutter develop coping and self-advocacy skills.
New molecular mechanism identified in common inherited heart disease
A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an international research team, has identified a new molecular mechanism involved in hypertrophic cardiomyopathy, the most common inherited cardiovascular disease.
Adaptor proteins regulate macrophage behavior to control cancer growth
A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression."
New drug candidate treats severe fatty liver disease by improving gut health
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.
New nonhormonal therapy shows promise for treating Genitourinary Syndrome of Menopause
Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM).
Microbiome science merges with oncology for better cancer treatments
Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies.
Study offers insight into how long-term inflammation may contribute to cognitive decline
The King's College London study, published in Nature Communications, offers insight into how long-term inflammation may contribute to cognitive decline in disorders such as Alzheimer's disease, aging, depression, and the lingering neurological effects of viral infections.
Gut microbiome changes can signal future type 2 diabetes risk
The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who go on to develop type 2 diabetes years later.
Eppendorf focuses outreach programs to advance STEM education in Europe
Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today highlights its European outreach activities dedicated to addressing persistent challenges in STEM education.
Beckman Coulter Diagnostics expands Alzheimer’s portfolio with CE-marked p-Tau217 blood test and new high-specificity research assay
Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline.
n6 appoints Broad Institute Principal Investigator Aziz Al'Khafaji as Scientific Advisor, advancing AutoNorm™ as the new standard in NGS library preparation
n6 Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well adaptive amplification (iconPCR™ with AutoNorm), today announced the appointment of Dr. Aziz Al'Khafaji as Scientific Advisor.
Phenolic compounds linked to precocious puberty or early breast development in girls
Research from the University of Granada, recently published in the European Journal of Pediatrics, has revealed that girls with higher levels of bisphenol A (a component of plastics and epoxy-phenolic resins) and benzophenones (ultraviolet filters) in their urine are more likely to experience precocious puberty or early breast development.
Study reveals long-term, intergenerational impacts of severe preconception trauma
Can the trauma of a parent rewrite the mental health of a child born decades later? A new compelling study reveals that children born decades after the Holocaust to parents who were older than age five at the time of the initial Nazi persecutions faced elevated schizophrenia risk.
Sustainable oyster meat extract may reduce human intestinal inflammation
Ongoing research provides evidence that readily-available and sustainable oyster meat extract may have powerful anti-inflammatory effects on human intestinal cells.
Estonian study highlights value of early genetic tests to identify hereditary cancer risks
In 2013, Angelina Jolie inspired a wave of testing for pathogenic variants of the gene BRCA1 by announcing that she carried a variant which left her at such high risk of breast cancer, she chose a preventive mastectomy.
U.S. obesity rates rose sharply between 1999 and 2023
Obesity rates among U.S. adults and children rose sharply in recent years and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published today in the American Heart Association's flagship journal Circulation.




